MORRIS PLAINS, N.J., Sept. 2, 2011 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that Gerard G. Gorman, Senior Vice President Finance and Chief Financial Officer, is scheduled to present an overview of the Company, including comments on the Company’s product portfolio, at the Stifel Nicolaus 2011 Healthcare Conference on Friday, September 9th at 10:55 am Eastern time at the Four Season Hotel in Boston, MA.
